Results 231 to 240 of about 13,286,607 (333)

Thalamic Neuromodulation: New Frontiers. [PDF]

Epilepsy Curr
Hsu J, Ali R, Air E, Englot D, Muh CR, Richardson RM, Rammo R.   +6 more
europepmc   +1 more source

Turbulent Drag Reduction by Biopolymers in Large Scale Pipes

, 2014
Marina Campolo, Mattia Simeoni, Romano Lapasin, Alfredo Soldati   +3 more
openalex   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Monomer and dimer pathways of earth-abundant manganese tricarbonyl pre-catalysts for CO₂ reduction studied by time-resolved IR spectroscopy.

Phys Chem Chem Phys
Tatarashvili L, von Fellenberg N, Oppelt K, Hamm P.   +3 more
europepmc   +1 more source

Two-stage surgical management for chronic volar lunate dislocation: a case report. [PDF]

Front Surg
Zhang L, Yu Y, Yang F, Peng J, Li J, Huang X, Deng X, Yang X, Yang L.   +8 more
europepmc   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Understanding dopaminergic dose reduction following STN-DBS: mediation analysis. [PDF]

BMJ Neurol Open
Lanore A, Houot M, Basset A, Bendetowicz D, Menon PJ, Bardinet E, Fernandez Vidal S, Cornillault J, Karachi C, Navarro S, Ihle J, Eusebio A, Giordana C, Rouaud T, Drapier S, Guehl D, Marques A, Hubsch C, Jarraya B, Benatru I, Thobois S, Hopes L, Maltete D, Rascol O, Tir M, Moreau C, Tranchant C, Rolland AS, Devos D, Corvol JC, Grabli D, Hainque E, PREDISTIM study group.   +32 more
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Laparoscopic Omental Lymph Node Flap Transfer for Lower Extremity Lymphedema: Insights into Lymphangiogenesis and Clinical Outcomes. [PDF]

Int J Med Sci
Eaimkijkarn C, Kanasup N, Rattanamahattana O, Chochai P, Sirimahachaiyakul P, Leethochavalit W, Suyabodha T, Chirawichada C, Saengprakai W, Tansawet A, Techapongsatorn S.   +10 more
europepmc   +1 more source